纳斯达克生物科技指数收涨1.55%。成分股Akero Therapeutics收涨22.71%，Sana Biotechnology涨22.02%，89bio涨20.97%表现第三，新冠疫苗概念股CureVac NV ADR涨10.47%、莫德纳涨6.31%表现靠前。Anavex Life Sciences则收跌9.95%表现倒数第三，Prime Medicine跌15.01%，Alumis跌16.89%。

Market Performance - The NASDAQ Biotechnology Index increased by 1.55%, closing at 4,177.9 points [1][2] - Notable gainers included Akero Therapeutics, which rose by 22.71%, and Sana Biotechnology, which increased by 22.02% [1][2] - Other significant performers were 89bio with a 20.97% rise, CureVac NV ADR up by 10.47%, and Moderna gaining 6.31% [1][2] Decliners - Anavex Life Sciences experienced a decline of 9.95%, while Prime Medicine fell by 15.01% [1][2] - Alumis saw a significant drop of 16.89% [1][2] Trading Volume - Akero Therapeutics had a trading volume of 6.77 million shares, while Sana Biotechnology traded 10.2 million shares [2] - 89bio recorded a trading volume of 7.16 million shares [2]